Inventor · disambiguated record
Michael J. Tisdale
Also filed as: TISDALE MICHAEL · TISDALE MICHAEL J · TISDALE MICHAEL JOHN
17 granted patents·25 pending applications·381 citations·filing 1989–2024
94Inventor score
Top patents by PatentIndex Score
42 records- 0193US5457130AEicosapentaenoic acid used to treat cachexiaCANCER RES CAMPAIGN TECH·Filed 1994·Granted Oct 10, 1995·191 cites·4 claims
- 0289US8217077B2HMB uses thereofBAXTER JEFFREY H·Filed 2004·Granted Jul 10, 2012·26 cites·6 claims
- 0386US8609725B2Method of using beta-hydroxy-beta-methylbutyrate for reducing tumor growth rateBAXTER JEFFREY H·Filed 2012·Granted Dec 17, 2013·6 cites·20 claims
- 0484US10172917B2Targeted oesophageal administration of ZN-α2-glycoproteins (ZAG), methods and formulations thereofUNIV ASTON·Filed 2016·Granted Jan 8, 2019·2 cites·14 claims
- 0584US5214797AMethod and apparatus for protection of skin against mosquitos and other insectsTISDALE MICHAEL·Filed 1991·Granted Jun 1, 1993·73 cites·11 claims
- 0684US2025134955A1Targeted oesophageal administration of zn-alpha2-glycoproteins (zag), methods and formulations thereofUNIV ASTON·Filed 2024·Application pending·0 cites
- 0782US2024301022A1Glycoproteins having lipid mobilizing properties and therapeutic uses thereofUNIV ASTON·Filed 2024·Application pending·0 cites
- 0881US2024000888A1Glycoproteins having lipid mobilizing properties and therapeutic uses thereofUNIV ASTON·Filed 2023·Application pending·0 cites
- 0980US8329646B2Methods for the treatment of muscle lossTISDALE MICHAEL JOHN·Filed 2006·Granted Dec 11, 2012·11 cites·39 claims
- 1077US7550429B2Glycoproteins having lipid mobilising properties and therapeutic applications thereofUNIV ASTON·Filed 2004·Granted Jun 23, 2009·3 cites·2 claims
- 1174US6890899B1Glycoproteins having lipid mobilizing properties and therapeutic applications thereofFiled 1999·Granted May 10, 2005·20 cites·2 claims
- 1273US10077295B2Glycoproteins having lipid mobilizing properties and therapeutic uses thereofUNIV ASTON·Filed 2016·Granted Sep 18, 2018·1 cites·16 claims
- 1373US2022211809A1Targeted oesophageal administration of zn-alpha2-glycoproteins (zag), methods and formulations thereofUNIV ASTON·Filed 2021·Application pending·0 cites
- 1472US2021315969A1Glycoproteins having lipid mobilizing properties and therapeutic uses thereofUNIV ASTON·Filed 2021·Application pending·0 cites
- 1569US2015183843A1Glycoproteins having lipid mobilising properties and therapeutic applications thereofUNIV ASTON·Filed 2014·Application pending·0 cites
- 1668US2019070258A1Targeted oesophageal administration of zn-alpha2-glycoproteins (zag), methods and formulations thereofUNIV ASTON·Filed 2018·Application pending·0 cites
- 1768US2010151589A1Glycoproteins Having Lipid Mobilising Properties and Therapeutic Applications ThereofUNIV ASTON·Filed 2009·Application pending·0 cites
- 1868US2020339642A1Glycoproteins having lipid mobilizing properties and therapeutic uses thereofUNIV ASTON·Filed 2020·Application pending·0 cites
- 1967US2020330554A1Glycoproteins having lipid mobilizing properties and therapeutic uses thereofUNIV ASTON·Filed 2020·Application pending·0 cites
- 2066US2010173829A1Glycoproteins Having Lipid Mobilizing Properties and Therapeutic Uses ThereofUNIV ASTON·Filed 2009·Application pending·0 cites
- 2165US2015202259A1Targeted oesophageal administration of zn-alpha2-glycoproteins (zag), methods and formulations thereofUNIV ASTON·Filed 2013·Application pending·0 cites
- 2264US2014242089A1Glycoproteins having lipid mobilising properties and therapeutic applications thereofUNIV ASTON·Filed 2014·Application pending·0 cites
- 2362US2018339019A1Glycoproteins having lipid mobilizing properties and therapeutic uses thereofUNIV ASTON·Filed 2018·Application pending·0 cites
- 2462US2019002512A1Glycoproteins having lipid mobilizing properties and therapeutic uses thereofUNIV ASTON·Filed 2018·Application pending·0 cites
- 2561US5385740ABiologically active material characterized by catabolic activity generally associated with cachexia-inducing tumors, preparations, production and uses thereofCANCER RES CAMPAIGN TECH·Filed 1992·Granted Jan 31, 1995·15 cites·3 claims
- 2661US2014243259A1Glycoproteins having lipid mobilizing properties and therapeutic uses thereofUNIV ASTON·Filed 2014·Application pending·0 cites
- 2760US8778994B2Method of using beta-hydroxy-beta-methylbutyrate and fatty acids for treating disease-associated wastingBAXTER JEFFREY H·Filed 2012·Granted Jul 15, 2014·0 cites·20 claims
- 2860US2014235534A1Glycoproteins having lipid mobilizing properties and therapeutic uses thereofUNIV ASTON·Filed 2014·Application pending·0 cites
- 2959US7049338B2Antiproliferative agentsAYUKO WASHINGTON ODUR·Filed 2005·Granted May 23, 2006·1 cites·14 claims
- 3057US2016046704A1Glycoproteins having lipid mobilising properties and therapeutic applications thereofUNIV ASTON·Filed 2015·Application pending·0 cites
- 3157US2005215640A1HMB compositions and uses thereofBAXTER JEFFREY H·Filed 2004·Application pending·0 cites
- 3256US2016220635A1Glycoproteins having lipid mobilizing properties and therapeutic uses thereofUNIV ASTON·Filed 2016·Application pending·0 cites
- 3353US6133278AUse of quinone and hydroquinone derivatives for the treatment of cachexiaTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1995·Granted Oct 17, 2000·15 cites·15 claims
- 3453US5219579ABiologically active material characterized by catabolic activity generally associated with cachexia-inducing tumors, preparations, production and uses thereofCANCER RES CAMPAIGN TECH·Filed 1989·Granted Jun 15, 1993·17 cites·9 claims
- 3553US2013143797A1Glycoproteins Having Lipid Mobilizing Properties an Therapeutic Uses ThereofTISDALE MICHAEL J·Filed 2011·Application pending·0 cites
- 3650US8207310B2Antibodies to proteolysis inducing factor (PIF) receptor and methods of use thereofTISDALE MICHAEL JOHN·Filed 2007·Granted Jun 26, 2012·0 cites·18 claims
- 3746US7750181B2Antiproliferative agentsEPX RES LTD·Filed 2005·Granted Jul 6, 2010·0 cites·10 claims
- 3845US6881846B2Antiproliferative agentsEPX RES LTD·Filed 2003·Granted Apr 19, 2005·0 cites·10 claims
- 3944US2009143301A1High calorie nutritional supplementNESTEC SA·Filed 2006·Application pending·0 cites
- 4041US2016361291A1Methods for increasing skeletal muscle protein synthesis using green tea extractABBOTT LAB·Filed 2014·Application pending·0 cites
- 4140US2011077198A1Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibitionTISDALE MICHAEL JOHN·Filed 2008·Application pending·0 cites
- 4238US2012301404A1Treatment of cachexiaTISDALE MICHAEL JOHN·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →